Medicare Enrolled
Dr. Ronald Pucillo, M.D.
Family Medicine · Sugar Land, TX
Practice pattern: Clinical Cardiology— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Pucillo from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Pucillo? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Pucillo
Dr. Ronald Pucillo is a family medicine in Sugar Land, TX, with 20 years in practice. Based on federal Medicare data, Dr. Pucillo performed 8,296 Medicare services across 2,769 unique beneficiaries.
Between the years covered by Open Payments, Dr. Pucillo received a total of $13,624 from 80 pharmaceutical and/or device companies across 879 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Pucillo is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice▲ Top 2% volume in TX$ $13,624 industry payments
Medicare Practice Summary
Medicare Utilization ↗8,296
Medicare services
Top 2% in TX for family medicine
2,769
Unique beneficiaries
$29
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~415 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Allergy immunotherapy preparation | 1,400 | $11 | $38 |
| Chronic care management, additional 20 min/month | 1,076 | $36 | $116 |
| Allergy skin test | 1,050 | $3 | $19 |
| Chronic care management, first 20 min/month | 747 | $47 | $131 |
| Allergy injection therapy, multiple injections | 431 | $8 | $31 |
| Office visit, established patient (30-39 min) | 319 | $78 | $330 |
| Comprehensive metabolic blood panel | 305 | $10 | $43 |
| Complete blood count (CBC) with differential | 289 | $8 | $32 |
| Lipid panel (cholesterol and triglycerides) | 281 | $13 | $55 |
| Thyroid stimulating hormone (TSH) test | 236 | $16 | $69 |
| Free thyroxine (T4) test | 224 | $9 | $37 |
| Hemoglobin A1c test (diabetes monitoring) | 175 | $10 | $40 |
| Complete ultrasound study of arm and leg arteries | 160 | $78 | $425 |
| Testing of autonomic nervous system function and heart rate response to deep breathing | 159 | $67 | $269 |
| Testing of autonomic (sympathetic) nervous system function | 159 | $89 | $587 |
| Remote patient monitoring management, 20 min/month | 107 | $37 | $157 |
| Management using the results of remote vital sign monitoring per calendar month, each additional 20 minutes | 107 | $30 | $129 |
| Advance care planning consultation, first 30 min | 87 | $80 | $261 |
| Thyroid hormone, t3 measurement, free | 80 | $17 | $69 |
| Ultrasound of both sides of head and neck blood flow | 75 | $124 | $620 |
| Annual wellness visit, follow-up | 72 | $123 | $357 |
| Remote patient monitoring device, 30 days | 68 | $37 | $195 |
| Testosterone (hormone) level, total | 67 | $25 | $105 |
| Sex hormone binding globulin (protein) level | 66 | $21 | $89 |
| Testosterone (hormone) level, free | 66 | $25 | $104 |
| Blood draw (venipuncture) | 61 | $8 | $10 |
| Ultrasound of leg arteries or artery grafts | 60 | $171 | $800 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 53 | $28 | $126 |
| Assessment of emotional or behavioral problems | 48 | $3 | $16 |
| Echocardiogram, transthoracic | 46 | $128 | $696 |
| Parathyroid hormone level test | 26 | $40 | $169 |
| Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional | 23 | $18 | $61 |
| Office visit, established patient (20-29 min) | 22 | $49 | $222 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 21 | $38 | $164 |
| Vitamin B-12 level test | 20 | $15 | $62 |
| Measurement of total estradiol (hormone) | 20 | $27 | $114 |
| Remote monitoring of physiologic parameters, initial set-up and patient education on use of equipment | 20 | $14 | $59 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 20 | $160 | $529 |
| Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen | 17 | $50 | $154 |
| Adm sarscv2 bvl 30mcg/.3ml a | 11 | $38 | $120 |
| Automated urinalysis | 11 | $2 | $9 |
| Prostate cancer screening; prostate specific antigen test (psa) | 11 | $19 | $75 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
0.6% high complexity
8.8% medium
90.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$13,624
Total received (2018-2024)
Avg $1,946/year across 7 years
Top 3% in TX for family medicine
80
Companies
879
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$13,603 (99.9%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$20 (0.1%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$1,808
2023$1,497
2022$1,888
2021$1,849
2020$2,076
2019$1,929
2018$2,575
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Novo Nordisk Inc
$1,344
Amgen Inc.
$1,137
Abbott Laboratories
$1,046
Amarin Pharma Inc.
$874
AstraZeneca Pharmaceuticals LP
$837
Lilly USA, LLC
$648
ABBVIE INC.
$536
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$493
PFIZER INC.
$475
GlaxoSmithKline, LLC.
$408
Boehringer Ingelheim Pharmaceuticals, Inc.
$384
Janssen Pharmaceuticals, Inc
$321
AbbVie Inc.
$301
Takeda Pharmaceuticals U.S.A., Inc.
$288
Endo Pharmaceuticals Inc.
$236
Merck Sharp & Dohme LLC
$222
SANOFI-AVENTIS U.S. LLC
$218
Merck Sharp & Dohme Corporation
$197
Horizon Therapeutics plc
$192
Allergan, Inc.
$190
Shire North American Group Inc
$189
Dexcom, Inc.
$185
Stryker Corporation
$172
Bayer HealthCare Pharmaceuticals Inc.
$162
Novartis Pharmaceuticals Corporation
$152
Eisai Inc.
$126
ARBOR PHARMACEUTICALS, INC.
$119
Astellas Pharma US Inc
$108
Corium, LLC
$105
Allergan Inc.
$104
Kowa Pharmaceuticals America, Inc.
$102
SANOFI PASTEUR INC.
$96
Exact Sciences Corporation
$89
IBSA Pharma Inc.
$83
Bayer Healthcare Pharmaceuticals Inc.
$81
RedHill Biopharma Inc.
$72
Antares Pharma, Inc.
$71
IRONWOOD PHARMACEUTICALS, INC
$67
Ironwood Pharmaceuticals, Inc
$62
Jazz Pharmaceuticals Inc.
$56
IDORSIA PHARMACEUTICALS US INC
$55
Avanir Pharmaceuticals, Inc.
$51
JAZZ PHARMACEUTICALS INC.
$47
Regeneron Healthcare Solutions, Inc.
$46
Biohaven Pharmaceutical Holding Company Ltd.
$43
Esperion Therapeutics, Inc.
$42
Medtronic, Inc.
$42
US WorldMeds, LLC
$41
Arbor Pharmaceuticals, Inc.
$39
EISAI INC.
$37
Renalytix AI, Inc.
$35
Corium, Inc.
$35
Synergy Pharmaceuticals Inc
$34
Biohaven Pharmaceuticals, Inc.
$32
Supernus Pharmaceuticals, Inc.
$28
AbbVie, Inc.
$28
ARALEZ PHARMACEUTICALS US INC.
$26
Egalet US Inc
$25
Lupin Inc.
$25
Gilead Sciences, Inc.
$24
Acclarent, Inc
$22
Zyla Life Sciences
$20
Genentech USA, Inc.
$20
Circassia Pharmaceuticals Inc
$20
Ironshore Pharmaceuticals Inc.
$19
Inspire Medical Systems, Inc.
$19
Noven Therapeutics, LLC
$19
Paratek Pharmaceuticals, Inc.
$18
Bardy Diagnostics, Inc.
$18
Nabriva Therapeutics, plc
$17
Currax Pharmaceuticals LLC
$17
Seqirus USA Inc
$16
Noden Pharma USA Inc
$16
Medtronic USA, Inc.
$16
Adlon Therapeutics L.P.
$15
Horizon Pharma plc
$15
Azurity Pharmaceuticals, Inc.
$14
Orexo US, Inc.
$13
Purdue Pharma L.P.
$12
Medtronic MiniMed, Inc.
$11
Top 3 companies account for 25.9% of total payments
Associated products mentioned in payments ›
ADHANSIA XR · AIRSUPRA · AREXVY · AVEED · AZSTARYS · Acclarent Aera · Aemcolo · Aimovig · Azstarys · BASAGLAR · BELSOMRA · BREZTRI AEROSPHERE · BYDUREON · BYSTOLIC · Belviq · CHANTIX · COLOGUARD · COLOGUARD DNA CAPTURE REAGENTS · CONTRAVE · CYCLOSET · Carnation Ambulatory Monitor · Cologuard Collection Kit · Creon · DEXCOM G6 CGM SYSTEM · DUEXIS · DUZALLO · Dayvigo · Dexcom G6 Transmitter · ELIQUIS · EMGALITY · ENTRESTO · EVENITY · Edarbi · Edarbyclor · Epclusa · FARXIGA · FLUBLOK QUADRIVALENT NORTHERN HEMISPHERE · FLUCELVAX QUADRIVALENT · FLUZONE HIGH-DOSE · FREESTYLE LIBRE · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GARDASIL · Horizant · INSPIRE · INTELLIS · INTELLIS ADAPTIVESTIM · INVOKANA · JANUVIA · JARDIANCE · JORNAY PM · KIDNEYINTELX BLOOD COLLECTION CONVENIENCE KIT · KRYSTEXXA · Kerendia · LEQVIO · LICART · LINZESS · LYRICA · Linzess · Livalo · Lucemyra/Lofexidine · MOUNJARO · MYDAYIS · MYRBETRIQ · Movantik · NASCOBAL · NEXLETOL · NOCDURNA · NUCALA · NUEDEXTA · NURTEC ODT · NUZYRA · Otezla · Ozempic · PENNSAID · PNEUMOVAX 23 · PRALUENT · PREVNAR - 13 · PREVNAR 13 · PREVNAR 20 · PROCLAIM · PROPHECY · Prolia · QELBREE · QULIPTA · QUVIVIQ · RAYOS · RELISTOR · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA · SOLIQUA 100/33 · SOLOSEC · SPRIX · STEGLATRO · SUNOSI · SUPRAX · SYMBICORT · SYMPROIC · SYNTHROID · Saxenda · TEKTURNA · TOUJEO · TRADJENTA · TRELEGY ELLIPTA · TRINTELLIX · TRULICITY · TUDORZA PRESSAIR · Talicia · Tirosint · Tresiba · Trintellix · Trulance · UBRELVY · VERQUVO · VIBERZI · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XIFAXANIBSD · XYOSTED · XYWAV · Xelstrym · Xenleta · Xofluza · Xyrem · ZEPBOUND · ZONTIVITY · ZORVOLEX · iPro2
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (100%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 3% for family medicine in TX.
Equivalent to $164 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
1,306
Per 100K population
151.9
County median income
$113,409
Nearest hospital
HOUSTON METHODIST SUGARLAND HOSPITAL
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Pucillo is a clinical cardiology specialist, with above-average Medicare volume (top 2% in TX), and high industry engagement (low-engagement, top 3%), with 20 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Pucillo experienced with allergy immunotherapy preparation?
Based on Medicare claims data, Dr. Pucillo performed 1,400 allergy immunotherapy preparation services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Pucillo receive payments from pharmaceutical companies?
Yes. Dr. Pucillo received a total of $13,624 from 80 companies across 879 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Pucillo's costs compare to other family medicines in Sugar Land?
Dr. Pucillo's average Medicare payment per service is $29. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Pucillo) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Sugar Land
Browse family medicines in Sugar Land ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
Abbott Laboratories Payments to Doctors
See all physicians who received payments from Abbott Laboratories.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology